Treatment of tubular damage in high-fat-diet-fed obese mice using sodium-glucose co-transporter inhibitors
暂无分享,去创建一个
S. Nagao | Satoshi Shimo | K. Nakajima | Kazuo Takahashi | Huy Bang Nguyen | T. Q. Thai | S. Saitoh | N. Ohno | T. Takaki | Kanako Kumamoto | K. Kunisawa | Akihiro Tojo | H. Terashima | Bao Wo
[1] Zijian Wu,et al. Dietary Supplementation of Apple Phlorizin Attenuates the Redox State Related to Gut Microbiota Homeostasis in C57BL/6J Mice Fed with a High-Fat Diet. , 2020, Journal of agricultural and food chemistry.
[2] S. Verma,et al. Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function. , 2020, Annual review of physiology.
[3] Jian Sun,et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction , 2020, Cell Death & Disease.
[4] Satoshi Shimo,et al. Sodium-glucose co-transporter (SGLT) inhibitor restores lost axonal varicosities of the myenteric plexus in a mouse model of high-fat diet-induced obesity , 2020, Scientific Reports.
[5] Kenji Tsuji,et al. Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice , 2020, International journal of molecular sciences.
[6] S. Saitoh,et al. Glomerular Cellular Interactions Following Disruption of the Glomerular Basement Membrane in IgA Nephropathy: Ultrastructural Analyses by 3-Dimensional Serial Block-Face Scanning Electron Microscopy , 2020, Kidney medicine.
[7] S. Saitoh,et al. Podocyte penetration of the glomerular basement membrane to contact on the mesangial cell at the lesion of mesangial interposition in lupus nephritis: a three-dimensional analysis by serial block-face scanning electron microscopy , 2019, Clinical and Experimental Nephrology.
[8] A. Durak,et al. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats , 2018, Cardiovascular Diabetology.
[9] A. Ballabio,et al. Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney , 2018, The Journal of pathology.
[10] Tetsuhiro Tanaka,et al. Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. , 2018, Kidney international.
[11] Christopher S. Hughes,et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.
[12] R. Eckel,et al. Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[13] H. Heerspink,et al. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. , 2018, Kidney international.
[14] A. Murphy,et al. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. , 2018, Atherosclerosis.
[15] D. Koya,et al. Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet , 2018, Journal of diabetes investigation.
[16] M. Czech. Insulin action and resistance in obesity and type 2 diabetes , 2017, Nature Medicine.
[17] Y. Isaka,et al. High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney. , 2017, Journal of the American Society of Nephrology : JASN.
[18] N. Câmara,et al. Kidney disease and obesity: epidemiology, mechanisms and treatment , 2017, Nature Reviews Nephrology.
[19] E. Tai,et al. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease , 2016, Kidney international reports.
[20] P. Greimel,et al. Separation and analysis of mono-glucosylated lipids in brain and skin by hydrophilic interaction chromatography based on carbohydrate and lipid moiety. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] N. Kitamura,et al. Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.
[22] P. Dorrestein,et al. Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator , 2016, EBioMedicine.
[23] A. Snider,et al. Sphingolipids in High Fat Diet and Obesity-Related Diseases , 2015, Mediators of inflammation.
[24] Katsumasa Fujita,et al. Sphingomyelin distribution in lipid rafts of artificial monolayer membranes visualized by Raman microscopy , 2015, Proceedings of the National Academy of Sciences.
[25] M. Coughlan,et al. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? , 2014, British journal of pharmacology.
[26] D. Bates,et al. Resolution of the three dimensional structure of components of the glomerular filtration barrier , 2014, BMC Nephrology.
[27] G. Schmitz,et al. Lipidomic Analysis of Serum from High Fat Diet Induced Obese Mice , 2014, International journal of molecular sciences.
[28] A. Tojo. The role of the kidney in protein metabolism: the capacity of tubular lysosomal proteolysis in nephrotic syndrome. , 2013, Kidney international.
[29] K. Sharma,et al. Autophagy and metabolic changes in obesity-related chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] T. Ideker,et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. , 2013, Journal of the American Society of Nephrology : JASN.
[31] E. Lerut,et al. Phlorizin Pretreatment Reduces Acute Renal Toxicity in a Mouse Model for Diabetic Nephropathy* , 2013, The Journal of Biological Chemistry.
[32] Faisal T Thayyullathil,et al. Role of ceramide in diabetes mellitus: evidence and mechanisms , 2013, Lipids in Health and Disease.
[33] C. Argmann,et al. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids , 2012, Journal of Lipid Research.
[34] Johannes E. Schindelin,et al. TrakEM2 Software for Neural Circuit Reconstruction , 2012, PloS one.
[35] B. Rothermel,et al. Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics. , 2012, The international journal of biochemistry & cell biology.
[36] C. Schnell,et al. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice , 2011, Human molecular genetics.
[37] Gregory Kaltsas,et al. Metabolic syndrome: definitions and controversies , 2011, BMC medicine.
[38] Gretchen A. Stevens,et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.
[39] E. Christensen,et al. Functional Ultrastructure of the Proximal Tubule , 2011 .
[40] M. Nangaku,et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[41] Jeremy C. Allegood,et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.
[42] N. Lewis,et al. Phlorizin: a review , 2005, Diabetes/metabolism research and reviews.
[43] M. Fartasch. The epidermal lamellar body: a fascinating secretory organelle. , 2004, The Journal of investigative dermatology.
[44] T. Hammond,et al. Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. , 1995, European journal of cell biology.
[45] G. Schmitz,et al. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. , 1991, Journal of lipid research.
[46] R. DeFronzo,et al. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.
[47] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.